The purpose of this research study is to improve cancer care for patients whose treatment outcomes have led to challenges in their quality of life. The study is randomized into 2 groups. Group 1 will receive a pre-rehabilitation referral in addition to their standard of care cancer treatment and Group 2 will resume their standard of care cancer treatment. Regardless of the group you are assigned to, all participants will answer questionnaires at baseline and at their 3-month follow-up.
You will answer questionnaires at baseline before your consultation visit. We will use a randomized to one of two groups. Group 1: Prehabilitation If you are selected to be part of Group 1, you will receive a prehabilitation referral. At this initial consultation the Cancer Rehabilitation Clinic will conduct a comprehensive evaluation, prepare an individualized treatment related to your cancer diagnosis and treatment needs and provide prehabilitation recommendations to continue exercises or therapy at home or in your local community. At this visit you will also complete a series of baseline questionnaires that should take approximately 30 minutes. This group will also have 1 follow up visit with the Cancer Rehabilitation Clinic approximately 6 weeks after the initial consultation. Approximately 3 months after your initial consultation you will complete a series of follow-up questionnaires about your health and opinion of the program (approximately 30 minutes). The study team will follow your health and cancer treatment by accessing your medical records for a total of 12 weeks from the time you enroll onto this study. Group 2: Standard of Care If you are selected to be part of Group 2, you will continue with your standard of care treatment without prehabilitation. You will complete the same series of baseline questionnaires as Group 1 (for approximately 30 minutes) if you are chosen to participate in this group. Approximately 3 months later you will be asked to complete follow-up questionnaires (approximately 30 minutes). The study team will follow your health and cancer treatment
Lineberger Comprehensive Cancer Center
NC Cancer Hospital (Basnight)
UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA
Christopher Jensen
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Bladder, Brain and Other Nervous System, Breast, Colorectal, Cervical, Head and Neck, Kidney, Liver, Lung, Melanoma, Pancreatic, Pediatric Cancers, Prostate, Sarcoma (bone and soft tissue), Stomach and Esophageal, Thyroid and Other Gland/Endocrine, Leukemia, Phase 1 Trials (all cancers), Lymphoma, Multiple Myeloma, Uterine (endometrial), Ovarian)
24-1423